Skip to main content

 9WXK | pdb_00009wxk

Linear fragment of lycosin9I with anti-MRSA activity


Experimental Data Snapshot

  • Method: SOLUTION NMR
  • Conformers Calculated: 200 
  • Conformers Submitted: 20 
  • Selection Criteria: structures with the least restraint violations 

wwPDB Validation 3D Report Full Report

Validation slider image for 9WXK

This is version 1.0 of the entry. See complete history. 

Literature

NMR Unveils Activity Mechanism of Linear Spider Venom Peptide Fragments Selected by Neural Networks Against Staphylococci Including MRSA.

Mironov, P.A., Baranova, A.A., Alferova, V.A., Egorova, N.S., Ignatova, A.A., Feofanov, A.V., Shenkarev, Z.O., Dubovskii, P.V.

(2025) Pharmaceutics 17

  • DOI: https://doi.org/10.3390/pharmaceutics17121526
  • Primary Citation Related Structures: 
    9WXK

  • PubMed Abstract: 

    Background/Objectives: Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant global health threat due to its increasing resistance to conventional antibiotics. Antimicrobial peptides (AMPs) derived from natural sources represent a promising alternative. Fragments of spider membrane-active toxins can serve as AMPs with anti-MRSA activity. Methods: To demonstrate this, amino acid sequences of approximately 2000 linear spider venom peptides were fragmented into 9-22-residue-long moieties (75,235 in total) and pre-trained neural networks were used to predict their anti-MRSA activity. As many as 15 peptides with high predicted activity were synthesized, and three AMPs with high anti-MRSA and low hemolytic activities were selected. One of these peptides was studied using high-resolution 1 H-, 13 C-, and 15 N-NMR spectroscopy in an aqueous solution and lyso-palmitoylphosphatidylglycerol (LPPG) micelles. Wide-line 31 P-NMR was applied to multilamellar phospholipid liposomes composed of phosphatidylcholine (PC) or phosphatidylglycerol (PG). Results : Low hemolytic activity is explained by non-specific interaction with PC whereas high antibacterial activity arises from specific interaction with PG accompanied with the formation of a tight complex between the N -terminal tripeptide fragment and PG headgroup. The structure of a such complex, stabilized by an ionic interaction between the N -terminal NH 3 + group and the lipid phosphate, was determined based on peptide-LPPG NOEs. The most favorable ratio between anti-MRSA and hemolytic activities, i.e., selectivity of the peptides, is attained when the tripeptide consists exclusively of phenylalanine and tryptophan residues. Confocal microscopy confirmed that the most selective peptide deteriorates the plasma membrane of S. aureus . Conclusions : This approach may enable the production of highly selective AMPs against Stapylococci , including MRSA.


  • Organizational Affiliation: 
    • Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 16/10 Miklukho-Maklaya str., Moscow 117997, Russia.

Macromolecule Content 

  • Total Structure Weight: 1.54 kDa 
  • Atom Count: 109 
  • Modeled Residue Count: 14 
  • Deposited Residue Count: 14 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:  Sequence   |   3D Structure  
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Lycosin 9i 3k14Lycosa erythrognathaMutation(s): 1 
UniProt
Find proteins for A0A8D8EPN3 (Lycosa hispanica)
Explore A0A8D8EPN3 
Go to UniProtKB:  A0A8D8EPN3
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupA0A8D8EPN3
Sequence Annotations
Expand
Reference Sequence

Experimental Data & Validation

Experimental Data

  • Method: SOLUTION NMR
  • Conformers Calculated: 200 
  • Conformers Submitted: 20 
  • Selection Criteria: structures with the least restraint violations 

Structure Validation

View Full Validation Report



Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Other governmentRussian FederationRussian Science Foundation 24-25-00160

Revision History  (Full details and data files)

  • Version 1.0: 2026-01-21
    Type: Initial release